192 related articles for article (PubMed ID: 23555712)
21. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma.
Liu Y; Zhang Y; Wen J; Liu L; Zhai X; Liu J; Pan S; Chen J; Shen H; Hu Z
PLoS One; 2012; 7(2):e32230. PubMed ID: 22393390
[TBL] [Abstract][Full Text] [Related]
22. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
23. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
26. Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Du Y; Zhang YW; Pu R; Han X; Hu JP; Zhang HW; Wang HY; Cao GW
Chin Med J (Engl); 2015 Apr; 128(8):1005-13. PubMed ID: 25881591
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
28. Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection.
Wang S; Xiang C; Mou L; Yang Y; Zhong R; Wang L; Sun C; Qin Z; Yang J; Qian J; Zhao Y; Wang Y; Pan X; Qie J; Jiang Y; Wang X; Yang Y; Zhou WP; Miao X; He F; Jin L; Wang H
Carcinogenesis; 2020 Apr; 41(2):146-158. PubMed ID: 31400761
[TBL] [Abstract][Full Text] [Related]
29. A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population.
Jiang L; Xu J; Ni J; Gao X; Zhu Z; Dong D; Wang X; Shi C; Tao X; Dong W; Gao Y
DNA Cell Biol; 2012 Sep; 31(9):1480-5. PubMed ID: 22731821
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Zhang H; Weng X; Ye J; He L; Zhou D; Liu Y
Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):600-9. PubMed ID: 25683523
[TBL] [Abstract][Full Text] [Related]
31. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
32. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
33. Rs4705342 polymorphism is involved in the tumorigenesis of HBV positive HCC by altering the binding affinity of HBV induced NF-kB with the promoter region of microRNA-143.
Yin X; Sun S; Zhao J; Yang J; Lei X; Xu C; Li K
J Cell Biochem; 2018 Jul; 119(7):5233-5242. PubMed ID: 29236306
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of DNA methylation in hepatocellular carcinoma.
Sceusi EL; Loose DS; Wray CJ
HPB (Oxford); 2011 Jun; 13(6):369-76. PubMed ID: 21609368
[TBL] [Abstract][Full Text] [Related]
35. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
36. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
[TBL] [Abstract][Full Text] [Related]
37. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
[TBL] [Abstract][Full Text] [Related]
38. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
[TBL] [Abstract][Full Text] [Related]
39. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
40. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
